M. Safarova

发表

Ig apheresis for the treatment of severe DCM patients.

A. I. Khaustov, M. Saidova, S. Pokrovsky, 2013, Atherosclerosis. Supplements.

Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype.

M. Ezhov, M. Safarova, O. Afanasieva, 2015, Atherosclerosis. Supplements.

A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR

Amy S. Shah, Marc S. Williams, W. Chung, 2019, npj Genomic Medicine.

Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.

M. Ezhov, M. Safarova, I. Adamova, 2013, Atherosclerosis. Supplements.

Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.

Hongfang Liu, I. Kullo, M. Safarova, 2016, Journal of clinical lipidology.

Effect of Lipoprotein Apheresis on Progression of Carotid Intima-Media Thickness in Patients with Severe Hypercholesterolemia.

M. Safarova, P. Moriarty, W. Thompson, 2022, The American journal of cardiology.

Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.

T. Balakhonova, M. Ezhov, M. Safarova, 2017, Atherosclerosis. Supplements.

Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.

O. Pogorelova, T. Balakhonova, M. Ezhov, 2015, Atherosclerosis. Supplements.

The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results

David C. Kochan, P. Caraballo, J. Olson, 2018, Mayo Clinic proceedings.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

Child-Parent Familial Hypercholesterolemia Screening in Primary Care.

I. Kullo, M. Safarova, 2017, The New England journal of medicine.

Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology.

I. Kullo, M. Safarova, 2018, Circulation research.

Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.

R. Akchurin, M. Ezhov, M. Safarova, 2017, Atherosclerosis. Supplements.

Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresis

M. Ezhov, M. Safarova, O. Afanasieva, 2015, Journal of clinical apheresis.

Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting.

M. Ezhov, M. Safarova, O. Afanasieva, 2014, Atherosclerosis.

A call for training programmes in cardiovascular genomics

I. Kullo, M. Ackerman, M. Safarova, 2021, Nature Reviews Cardiology.

Lipoprotein(a) lowering and cardiovascular risk reduction by PCSK9 inhibitors.

I. Kullo, M. Safarova, 2022, Atherosclerosis.

Variance in niacin response in individuals with elevated lipoprotein(a).

M. Ezhov, M. Safarova, 2014, Journal of clinical lipidology.

Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins.

R. Akchurin, M. Ezhov, M. Safarova, 2013, Atherosclerosis. Supplements.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Genetic basis of hypercholesterolemia in adults

David C. Kochan, J. Olson, I. Kullo, 2021, NPJ genomic medicine.

Variability in assigning pathogenicity to incidental findings: insights from LDLR sequence linked to the electronic health record in 1013 individuals

J. Olson, S. Bielinski, I. Kullo, 2017, European Journal of Human Genetics.

My Approach to the Patient With Familial Hypercholesterolemia.

I. Kullo, M. Safarova, 2016, Mayo Clinic proceedings.

Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry

Amy S. Shah, T. Assimes, T. Manolio, 2021, Circulation. Genomic and precision medicine.

Using the electronic health record for genomics research.

Iftikhar J Kullo, Maya S Safarova, I. Kullo, 2020, Current opinion in lipidology.

Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Atrial Fibrillation.

S. Ranka, M. Safarova, Rajat S Barua, 2022, The American journal of cardiology.

The Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Myocardial Infarction and Mortality

S. Ranka, M. Safarova, D. Parashara, 2021, Journal of the Endocrine Society.

Association of Genetic Risk of Obesity with Postoperative Complications Using Mendelian Randomization

Jamie R. Robinson, John J. Connolly, Nephi A. Walton, 2019, World Journal of Surgery.

Association between triglycerides, known risk SNVs and conserved rare variation in SLC25A40 in a multi-ancestry cohort

Amy S. Shah, John J. Connolly, H. Hakonarson, 2021, BMC medical genomics.

A Clinical Decision Support Tool for Familial Hypercholesterolemia Based on Physician Input

P. Caraballo, I. Kullo, A. Kumbamu, 2018, Mayo Clinic proceedings. Innovations, quality & outcomes.

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels

M. Ezhov, M. Safarova, O. Afanasieva, 2019, Biomolecules.

Targeted Sequencing Study to Uncover Shared Genetic Susceptibility Between Peripheral Artery Disease and Coronary Heart Disease-Brief Report.

D. Schaid, I. Kullo, J. Hopewell, 2019, Arteriosclerosis, thrombosis, and vascular biology.

Association of Intima‐Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta‐Analysis of 20 Prospective Studies

N. Sattar, L. Lind, P. Calder, 2023, Journal of the American Heart Association.

[Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels].

S. N. Pokrovskii, M. Ezhov, M. Safarova, 2011, Kardiologiia.

A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR

Amy S. Shah, Marc S. Williams, W. Chung, 2019, npj Genomic Medicine.

Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)

M. Safarova, P. Moriarty, 2023, Current Atherosclerosis Reports.

Association of a Family History of Coronary Heart Disease With Initiation of Statin Therapy in Individuals at Intermediate Risk: Post Hoc Analysis of a Randomized Clinical Trial.

K. Bailey, I. Kullo, M. Safarova, 2016, JAMA cardiology.

Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.

Hongfang Liu, I. Kullo, M. Safarova, 2016, Journal of clinical lipidology.

The Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Myocardial Infarction and Mortality

S. Ranka, M. Safarova, D. Parashara, 2021, Journal of the Endocrine Society.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

G. Francis, Qian Wang, D. Gaudet, 2021, Lancet.